April Pun, Vice-President, Athyrium Capital Management

April Pun

Vice President


April Pun joined Athyrium in 2018 and currently serves as a Vice President. April focuses on investments within the biotech, pharma, and consumer healthcare sectors. Representative investments include financings for Puma Biotechnology, Basilea, Revance Therapeutics, RVL Pharmaceuticals and BioCryst Pharmaceuticals.

Prior to joining Athyrium, April was in the Investment Banking Global Healthcare group at Bank of America Merrill Lynch. In that role, April focused on M&A, public and private capital raising, licensing deals, and a wide scope of advisory work for biotechnology and pharmaceutical companies.

April graduated with a B.S.E. in Biomedical Engineering with a minor in Finance from Duke University.